Bencsik K - Search Results

1

The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.

Biernacki T, Sandi D, Füvesi J, Fricska-Nagy Z, Kincses TZ, Ács P, Rózsa C, Dobos E, Cseh B, Horváth L, Nagy Z, Csányi A, Kovács K, Csépány T, Vécsei L, Bencsik K; on the behalf of the study investigators. Biernacki T, et al. Among authors: bencsik k. PLoS One. 2022 Apr 22;17(4):e0267346. doi: 10.1371/journal.pone.0267346. eCollection 2022. PLoS One. 2022. PMID: 35452476 Free PMC article.

2

Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines.

Pályi I, Kremmer T, Kálnay A, Turi G, Mihalik R, Bencsik K, Boldizsár M. Pályi I, et al. Among authors: bencsik k. Anticancer Drugs. 1999 Jan;10(1):103-11. doi: 10.1097/00001813-199901000-00013. Anticancer Drugs. 1999. PMID: 10194553

3

The prevalence of multiple sclerosis in the Hungarian city of Szeged.

Bencsik K, Rajda C, Klivényi P, Járdánházy T, Vécsei L. Bencsik K, et al. Acta Neurol Scand. 1998 May;97(5):315-9. doi: 10.1111/j.1600-0404.1998.tb05959.x. Acta Neurol Scand. 1998. PMID: 9613561

4

[Diagnostic studies of cerebrospinal fluid in patients with multiple sclerosis].

Seres E, Bencsik K, Rajda C, Vécsei L. Seres E, et al. Among authors: bencsik k. Orv Hetil. 1998 Aug 9;139(32):1905-8. Orv Hetil. 1998. PMID: 9731446 Hungarian.

5

[Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b].

Bencsik K, Rajda C, Klivényi P, Járdánházy T, Török M, Vécsei L. Bencsik K, et al. Orv Hetil. 1999 Apr 4;140(14):763-6. Orv Hetil. 1999. PMID: 10224846 Clinical Trial. Hungarian.

6

Nonenzymatic antioxidants of blood in multiple sclerosis.

Karg E, Klivényi P, Németh I, Bencsik K, Pintér S, Vécsei L. Karg E, et al. Among authors: bencsik k. J Neurol. 1999 Jul;246(7):533-9. doi: 10.1007/s004150050399. J Neurol. 1999. PMID: 10463352

7

The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary.

Bencsik K, Rajda C, Füvesi J, Klivényi P, Járdánházy T, Török M, Vécsei L. Bencsik K, et al. Eur Neurol. 2001;46(4):206-9. doi: 10.1159/000050806. Eur Neurol. 2001. PMID: 11721128

8

Experiences with interferon-beta-1b treatment in MS after three year follow-up.

Bencsik K, Rajda C, Füvesi J, Járdánházy T, Török M, Vécsei L. Bencsik K, et al. Swiss Med Wkly. 2002 May 4;132(17-18):237. doi: 10.4414/smw.2002.09810. Swiss Med Wkly. 2002. PMID: 12087490 Free article. No abstract available.

9

Familial multiple sclerosis: case study of three affected siblings.

Bencsik K, Rajda C, Seres E, Vörös E, Janáky M, Dibó G, Járdánházy T, Vécsei L. Bencsik K, et al. Acta Neurol Scand. 2002 Dec;106(6):392-5. doi: 10.1034/j.1600-0404.2002.01348.x. Acta Neurol Scand. 2002. PMID: 12460148

10

A genome-wide screen for association in Hungarian multiple sclerosis.

Rajda C, Bencsik K, Seres E, Jonasdottir A, Foltynie T, Sawcer S, Benediktsson K, Fossdal R, Setakis E, Compston A, Vécsei L. Rajda C, et al. Among authors: bencsik k. J Neuroimmunol. 2003 Oct;143(1-2):84-7. doi: 10.1016/j.jneuroim.2003.08.017. J Neuroimmunol. 2003. PMID: 14575920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters